Vallon Pharmaceuticals Inc
(VLON)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VLON | EVGN | ACXP | ||
| Company | Vallon Pharmaceuticals Inc | Evogene Ltd Ord | Acurx Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.4200 | 1.0000 | 2.07 | ||
| High | 0.4308 | 1.0800 | 2.09 | ||
| Low | 0.3803 | 0.9700 | 1.91 | ||
| Latest | 0.4000 | 1.0200 | 1.96 | ||
| Change | -0.0600 | +0.0100 | -0.10 | ||
| % Change | -13.04% | +0.99% | -4.85% | ||
| Volume | 1,113,400 | 605,500 | 41,300 | ||
| 20-Day Average Volume | 734,190 | 1,207,155 | 42,145 | ||
| Previous Close | 0.4600 | 1.0100 | 2.06 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.4018 | 1.0469 | 2.44 | ||
| 20-Day Raw Stochastic | 34.78% | 18.52% | 7.00% | ||
| 20-Day Relative Strength | 48.75 | 45.32 | 30.94 | ||
| Weighted Alpha | -68.20 | -34.89 | -91.70 | ||
| Today's Opinion | 48% Buy | 100% Sell | 100% Sell | ||
| Previous Opinion | 48% Buy | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 56% Buy | 80% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.50% since 04/14/23 | -6.42% since 02/04/26 | -6.67% since 02/04/26 | ||
| Low | 0.3622 on 04/17/23 | 0.9700 on 02/11/26 | 1.89 on 02/05/26 | ||
| High | 0.5500 on 04/20/23 | 1.1900 on 02/10/26 | 2.26 on 02/06/26 | ||
| 1-Month | |||||
| %Chg | -2.70% since 03/21/23 | -8.11% since 01/09/26 | -33.11% since 01/09/26 | ||
| Low | 0.3200 on 04/05/23 | 0.9700 on 02/11/26 | 1.89 on 02/05/26 | ||
| High | 0.5500 on 04/20/23 | 1.2400 on 02/04/26 | 2.92 on 01/12/26 | ||
| 3-Month | |||||
| %Chg | +36.75% since 01/20/23 | -17.74% since 11/11/25 | -64.87% since 11/11/25 | ||
| Low | 0.2562 on 01/26/23 | 0.9300 on 12/30/25 | 1.89 on 02/05/26 | ||
| High | 1.2300 on 02/13/23 | 1.2800 on 11/12/25 | 5.50 on 11/12/25 | ||
| 6-Month | |||||
| %Chg | +24.22% since 10/21/22 | -15.70% since 08/11/25 | -56.25% since 08/11/25 | ||
| Low | 0.2054 on 10/28/22 | 0.9300 on 12/30/25 | 1.89 on 02/05/26 | ||
| High | 1.2300 on 02/13/23 | 1.5000 on 10/08/25 | 8.34 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,393 | 5,419 | 5,246 | ||
| Shares Outstanding, K | 13,482 | 5,365 | 2,547 | ||
| Annual Sales | 0 | 8,510,000 | 0 | ||
| Annual Net Income | -7,020,000 | -16,490,000 | -14,100,000 | ||
| Last Quarter Sales | 0 | 310,000 | 0 | ||
| Last Quarter Net Income | -1,583,000 | 3,870,000 | -1,990,000 | ||
| 60-Month Beta | -1.14 | 1.35 | -1.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 02/24/23 | -0.31 on 11/20/25 | -1.23 on 11/12/25 | ||
| Latest Earnings Date | 05/08/23 | 03/05/26 | 03/16/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||